These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Lack of pediatric drug formulations. Nahata MC Pediatrics; 1999 Sep; 104(3 Pt 2):607-9. PubMed ID: 10469800 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and therapeutic drug monitoring of psychotropic drugs in pediatrics. Pichini S; Papaseit E; Joya X; Vall O; Farré M; Garcia-Algar O; de laTorre R Ther Drug Monit; 2009 Jun; 31(3):283-318. PubMed ID: 19363463 [TBL] [Abstract][Full Text] [Related]
5. Linezolid pharmacokinetics in pediatric patients: an overview. Jungbluth GL; Welshman IR; Hopkins NK Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S153-7. PubMed ID: 14520140 [TBL] [Abstract][Full Text] [Related]
6. Prescribing medications in pediatrics: concerns regarding FDA approval and pharmacokinetics. Novak E; Allen PJ Pediatr Nurs; 2007; 33(1):64-70. PubMed ID: 17411005 [TBL] [Abstract][Full Text] [Related]
7. Antibacterial agents in pediatrics. Chavez-Bueno S; Stull TL Infect Dis Clin North Am; 2009 Dec; 23(4):865-80, viii. PubMed ID: 19909888 [TBL] [Abstract][Full Text] [Related]
8. [General problems posed by prescription medications in children. Point of view of the clinician]. Guillot M Therapie; 1989; 44(2):133-5. PubMed ID: 2756518 [TBL] [Abstract][Full Text] [Related]
9. The position of the pharmaceutical industry in the development of drugs for pediatric use. Christensen CN Pediatr Pharmacol (New York); 1980; 1(1):15-9. PubMed ID: 7346727 [TBL] [Abstract][Full Text] [Related]
10. The economics of pediatric formulation development for off-patent drugs. Milne CP; Bruss JB Clin Ther; 2008 Nov; 30(11):2133-45. PubMed ID: 19108801 [TBL] [Abstract][Full Text] [Related]
11. Improving pediatric dosing through pediatric initiatives: what we have learned. Rodriguez W; Selen A; Avant D; Chaurasia C; Crescenzi T; Gieser G; Di Giacinto J; Huang SM; Lee P; Mathis L; Murphy D; Murphy S; Roberts R; Sachs HC; Suarez S; Tandon V; Uppoor RS Pediatrics; 2008 Mar; 121(3):530-9. PubMed ID: 18310202 [TBL] [Abstract][Full Text] [Related]
12. A comparison of Canadian general pediatric dosing publications. Dayneka N Can J Clin Pharmacol; 2003; 10(3):107-10. PubMed ID: 14506508 [TBL] [Abstract][Full Text] [Related]
13. [The action of synthetic anti-inflammatory agents in the oral surgical treatment of ambulatory patients]. Castagnola L; Garberoglio R; Scotti S Odontoiatr Prat; 1969 Jan; 4(13):9-19. PubMed ID: 4391199 [No Abstract] [Full Text] [Related]
14. Criteria supporting the study of drugs in the newborn. Ward RM; Benitz WE; Benjamin DK; Blackmon L; Giacoia GP; Hudak M; Lasky T; Rodriguez W; Selen A Clin Ther; 2006 Sep; 28(9):1385-98. PubMed ID: 17062311 [TBL] [Abstract][Full Text] [Related]
15. Drug therapy in pediatrics: a developing field. Mathis L; Rodriguez W Dermatol Ther; 2009; 22(3):257-61. PubMed ID: 19453350 [TBL] [Abstract][Full Text] [Related]
16. [Computer simulations to support drug therapy in children]. Breddemann A; Läer S Med Monatsschr Pharm; 2008 Nov; 31(11):429-33. PubMed ID: 19055162 [TBL] [Abstract][Full Text] [Related]
17. [Hazards of modern therapy in the pediatric practice]. Kosenow W Z Allgemeinmed; 1970 Sep; 46(26):1279-86. PubMed ID: 5522824 [No Abstract] [Full Text] [Related]